避妊製品の世界市場レポート 2025年

避妊製品の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.0％で、408億9,000万米ドルに成長します。予測期間の成長は、男性用避妊製品への注目の高まり、開発途上諸国における避妊へのアクセスの増加、避妊におけるデジタルヘルス技術の統合、長時間作用型可逆的避妊薬（LARCS）の需要の高まり、オンラインプラットフォームにおける市販薬へのアクセスの増加などに起因すると考えられます。予測期間における主な動向としては、避妊法の技術的進歩、非ホルモン性避妊法および自然な避妊法へのシフト、特定の避妊製品の店頭入手の拡大、ユーザーフレンドリーで目立たない避妊オプションの重視、避妊カウンセリングおよび処方における遠隔医療の統合などが挙げられます。

性感染症や性病の頻度の増加が、避妊製品の需要を牽引しています。性感染症（STDs）とは、性的な交流を通じて人から人へ感染する感染症です。最も典型的な接触は、肛門性交、口腔性交、膣性交で起こりますが、その他の密接な身体的接触方法でも感染する可能性があります。避妊製品は、ヘルペスやHPVのような性感染症のトランスミッションを管理するために採用されており、主に皮膚と皮膚の接触を通じて行われます。例えば、2023年5月、米国ミネソタ州の州保健機関であるミネソタ州保健局によると、原発性梅毒と続発性梅毒の症例数は、2021年の564例から2022年には676例と19％上昇しました。2022年には、乳児の先天梅毒が20例記録されました。これは、先天梅毒が14例記録された2021年から42％の上昇です。したがって、性感染症や性病の増加は、予測期間中に避妊製品の需要を押し上げると予想されます。

世界の人口率の上昇は、今後数年間における避妊製品市場の成長を促進すると予想されます。人口とは、特定の地理的地域、国、または地球全体に住む個体、種、または人々の総数を指します。避妊製品は、夫婦や個人が世帯の人数や子供の間隔を調整・計画できるようにすることで、人口減少に重要な役割を果たしています。例えば、2022年12月、スイスに本部を置く国連貿易開発会議（国連事務局内の政府間機関であり、国際商取引における発展途上国の利益を促進する）によると、世界人口は2021年に0.9％増加し、2022年には80億人を超えると予想されています。したがって、世界の人口増加が避妊製品市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界の避妊製品PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の避妊製品市場成長率分析
• 世界の避妊製品市場の実績：規模と成長, 2019-2024
• 世界の避妊製品市場の予測：規模と成長, 2024-2029, 2034F
• 世界の避妊製品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の避妊製品市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口避妊薬
• 局所避妊薬
• 注射剤
• ダイヤフラム
• 膣リング
• コンドーム
• 避妊スポンジ
• 皮下インプラント
• 子宮内避妊器具
• 世界の避妊製品市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 15～24歳
• 25～34歳
• 35～44歳
• 44歳
• 世界の避妊製品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 独立薬局
• オンライン薬局
• クリニック
• その他の流通チャネル
• 世界の避妊製品市場：経口避妊薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 複合薬
• プロゲスチンのみのピル
• 世界の避妊製品市場：局所避妊薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮パッチ
• ゲルの用途
• 世界の避妊製品市場：注射剤のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン注射剤
• 非ホルモン注射剤
• 世界の避妊製品市場：ダイアフラムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シリコンダイヤフラム
• ラテックス製ダイヤフラム
• 世界の避妊製品市場：膣リングのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモンリング
• 非ホルモンリング
• 世界の避妊製品市場：コンドームのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 男性用コンドーム
• 女性用コンドーム
• 世界の避妊製品市場：避妊スポンジのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ホルモンスポンジ
• ホルモンスポンジ
• 世界の避妊製品市場：皮下インプラントのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモンインプラント
• 非ホルモン性インプラント
• 世界の避妊製品市場：子宮内避妊器具（IUD）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン性IUD
• 銅製IUD

第7章 地域別・国別分析

• 世界の避妊製品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の避妊製品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 避妊製品市場：競合情勢
• 避妊製品市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Church & Dwight Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Cipla Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Reckitt Benckiser Group plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Agile Therapeutics Inc.
• Allergan Ltd.
• Aurobindo Pharma Limited
• Famy Care Ltd.
• Glenmark Pharmaceuticals Limited
• HLL Lifecare Limited
• Johnson & Johnson
• Laboratoire HRA Pharma SAS
• Lupin Limited
• Mankind Pharma Ltd.
• Mayer Laboratories Inc.
• Medisafe Distribution Inc.
• Mithra Pharmaceuticals SA
• Mylan NV
• Okamoto Industries Inc.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 避妊製品市場2029年-最も新しい機会を提供する国
• 避妊製品市場2029年-最も新しい機会を提供するセグメント
• 避妊製品市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Contraceptive refers to a method or act that involves the use of a variety of medicines, sexual behaviours, chemicals, medications, or surgical procedures to intentionally prevent conception. Contraceptive is any method, measure, or action designed to keep a woman from getting pregnant.

The main product types of contraceptives include oral contraceptive pills, topical contraceptives, injectables, diaphragms, vaginal rings, condoms, contraceptive sponges, subdermal implants, and intra-uterine devices. Oral contraceptive pills are contraceptive tablets or birth control pills to prevent pregnancy. It includes hormones that prevent eggs from being released from the ovaries. The contraceptives are used by a wide range of age groups, ranging from 15-24 years, 25-34 years, 35-44 years, and over 44 years. The contraceptives are distributed by clinics, hospitals, independent pharmacies, and other locations.

The contraceptives market research report is one of a series of new reports from The Business Research Company that provides contraceptives market statistics, including contraceptives industry global market size, regional shares, competitors with a contraceptives market share, detailed contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptives industry. This contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The contraceptives market size has grown strongly in recent years. It will grow from $27.92 billion in 2024 to $30.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to introduction of The birth control pill, increased awareness and education about contraception, legal and social changes promoting reproductive rights, global population control initiatives, increase inThe use of generic and low-cost drugs and devices.

The contraceptives market size is expected to see strong growth in the next few years. It will grow to $40.89 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing focus on male contraceptives, increased access to contraception in developing countries, integration of digital health technologies in contraception, rising demand for long-acting reversible contraceptives (LARCS), growing accessibility to over-the-counter drugs on the online platform. Major trends in the forecast period include technological advancements in contraceptive methods, shift towards non-hormonal and natural contraceptive methods, expansion of over-the-counter access to certain contraceptives, emphasis on user-friendly and discreet contraceptive options, integration of telemedicine in contraceptive counseling and prescriptions.

The rising frequency of sexually transmitted illnesses or diseases is driving the demand for contraceptives. Sexually transmitted diseases (STDs) are infections spread from one person to another through sexual interaction. The most typical contact occurs during anal, oral, and vaginal intercourse and they can spread through other close physical contact methods. Contraceptives are employed to manage the transmission of sexually transmitted diseases like herpes and HPV, primarily through skin-to-skin contact. For instance, in May 2023, according to the Minnesota Department of Health, a US-based state health agency of the State of Minnesota, primary and secondary syphilis cases climbed 19% in 2022, from 564 in 2021 to 676 in 2022. In 2022, 20 instances of congenital syphilis in babies were recorded. This represents a 42 % rise from 2021 when 14 cases of congenital syphilis were documented. Therefore, the increase in sexually transmitted illnesses or diseases is expected to boost the demand for contraceptives during the forecast period.

The global rise in population rates is expected to propel the growth of the contraceptive market in the coming years. Population refers to the overall number of individuals, species, or people living in a certain geographic region, country, or the entire planet. Contraceptives play a significant part in decreasing population by allowing couples and individuals to regulate and plan their household size and child spacing. For instance, in December 2022, according to the United Nations Conference on Trade and Development, a Switzerland-based intergovernmental body inside the United Nations Secretariat that promotes developing nations' interests in global commerce, the global population is expected to have increased by 0. 9% in 2021 and to exceed 8 billion by 2022. Therefore, the global rise in population rates is driving the contraceptive market.

Major companies in the contraceptives market are concentrating on developing innovative products such as Single Rod Subdermal Implants and Subcutaneous Injectable Contraceptives to improve user convenience, boost effectiveness, and provide long-term birth control solutions. These advancements aim to minimize the need for frequent dosing, enhance accessibility, and reduce side effects, offering more reliable and discreet contraceptive options for individuals seeking improved reproductive health management. For example, in October 2023, India's Health and Family Welfare Ministry introduced two new methods-the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive-under the National Family Planning Programme to enhance family planning services. These methods are designed to improve maternal and infant health outcomes by offering more family planning options. The introduction of these contraceptives aims to lower maternal and infant morbidity and mortality rates. This initiative is part of a larger effort to improve reproductive health services in Karnataka, ensuring that women have access to safe and effective contraceptive methods.

Major companies operating in the contraceptives market are focusing on innovative products, such as Opill, progestin-only daily oral contraceptives, to better meet the needs of their existing consumers. Opill progestin-only daily oral contraceptives, often known as the mini-pill, are a kind of birth control pill that includes just progestin, a synthetic version of the hormone progesterone. For instance, in July 2023, Perrigo Company plc, an Ireland-based manufacturing company of over-the-counter pharmaceuticals, announced U. S. Food and Drug Administration (FDA) approval for Opill progestin-only daily oral contraceptives. Opill is the very first birth control pill available without a prescription in the United States. Opill can significantly improve women's availability of contraceptives and is a genuine testament to Perrigo's constant dedication to delivering meaningful solutions that improve people's lives.

In March 2024, Insud Pharma, a Spain-based pharmaceutical manufacturer, acquired oral and injectable contraceptives from Viatris for an undisclosed amount. This acquisition allows Insud Pharma to strengthen its women's health product portfolio by incorporating Viatris' contraceptive offerings, expanding its market presence, and providing a wider range of reproductive healthcare solutions to meet the increasing demand for contraceptive options. Viatris, a US-based pharmaceutical company, specializes in the manufacturing of pharmaceuticals.

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The contraceptive market consists of sales of combined pills, Contraceptive patch, and female condoms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contraceptives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Oral Contraceptive Pills; Topical Contraceptives; Injectables; Diaphragms; Vaginal Rings; Condoms; Contraceptive Sponges; Subdermal Implants; Intra-Uterine Devices
• 2) By Age Group: 15-24 Years; 25-34 Years; 35-44 Years; 44 Years
• 3) By Distribution Channel: Hospital Pharmacies; Independent Pharmacies; Online Pharmacies; Clinics; Other Distribution Channels
• Subsegments:
• 1) By Oral Contraceptive Pills: Combination Pills; Progestin-Only Pills
• 2) By Topical Contraceptives: Transdermal Patches; Gel Applications
• 3) By Injectables: Hormonal Injectables; Non-Hormonal Injectables
• 4) By Diaphragms: Silicone Diaphragms; Latex Diaphragms
• 5) By Vaginal Rings: Hormonal Rings; Non-Hormonal Rings
• 6) By Condoms: Male Condoms; Female Condoms
• 7) By Contraceptive Sponges: Non-Hormonal Sponges; Hormonal Sponges
• 8) By Subdermal Implants: Hormonal Implants; Non-Hormonal Implants
• 9) By Intra-Uterine Devices (IUDs): Hormonal IUDs; Copper IUDs
• Companies Mentioned: Merck & Co. Inc.; Bayer AG; Church & Dwight Co. Inc.; Cipla Inc.; Reckitt Benckiser Group plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Contraceptives Market Characteristics

3. Contraceptives Market Trends And Strategies

4. Contraceptives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Contraceptives Growth Analysis And Strategic Analysis Framework

• 5.1. Global Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Contraceptives Market Growth Rate Analysis
• 5.4. Global Contraceptives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Contraceptives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Contraceptives Total Addressable Market (TAM)

6. Contraceptives Market Segmentation

• 6.1. Global Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Contraceptive Pills
• Topical Contraceptives
• Injectables
• Diaphragms
• Vaginal Rings
• Condoms
• Contraceptive Sponges
• Subdermal Implants
• Intra-Uterine Devices
• 6.2. Global Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15-24 Years
• 25-34 Years
• 35-44 Years

44 Years

• 6.3. Global Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Independent Pharmacies
• Online Pharmacies
• Clinics
• Other Distribution Channels
• 6.4. Global Contraceptives Market, Sub-Segmentation Of Oral Contraceptive Pills, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Pills
• Progestin-Only Pills
• 6.5. Global Contraceptives Market, Sub-Segmentation Of Topical Contraceptives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transdermal Patches
• Gel Applications
• 6.6. Global Contraceptives Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Injectables
• Non-Hormonal Injectables
• 6.7. Global Contraceptives Market, Sub-Segmentation Of Diaphragms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Silicone Diaphragms
• Latex Diaphragms
• 6.8. Global Contraceptives Market, Sub-Segmentation Of Vaginal Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Rings
• Non-Hormonal Rings
• 6.9. Global Contraceptives Market, Sub-Segmentation Of Condoms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male Condoms
• Female Condoms
• 6.10. Global Contraceptives Market, Sub-Segmentation Of Contraceptive Sponges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Hormonal Sponges
• Hormonal Sponges
• 6.11. Global Contraceptives Market, Sub-Segmentation Of Subdermal Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Implants
• Non-Hormonal Implants
• 6.12. Global Contraceptives Market, Sub-Segmentation Of Intra-Uterine Devices (IUDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal IUDs
• Copper IUDs

7. Contraceptives Market Regional And Country Analysis

• 7.1. Global Contraceptives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Contraceptives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contraceptives Market

• 8.1. Asia-Pacific Contraceptives Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contraceptives Market

• 9.1. China Contraceptives Market Overview
• 9.2. China Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contraceptives Market

• 10.1. India Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contraceptives Market

• 11.1. Japan Contraceptives Market Overview
• 11.2. Japan Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contraceptives Market

• 12.1. Australia Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contraceptives Market

• 13.1. Indonesia Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contraceptives Market

• 14.1. South Korea Contraceptives Market Overview
• 14.2. South Korea Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contraceptives Market

• 15.1. Western Europe Contraceptives Market Overview
• 15.2. Western Europe Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contraceptives Market

• 16.1. UK Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contraceptives Market

• 17.1. Germany Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contraceptives Market

• 18.1. France Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contraceptives Market

• 19.1. Italy Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contraceptives Market

• 20.1. Spain Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contraceptives Market

• 21.1. Eastern Europe Contraceptives Market Overview
• 21.2. Eastern Europe Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contraceptives Market

• 22.1. Russia Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contraceptives Market

• 23.1. North America Contraceptives Market Overview
• 23.2. North America Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contraceptives Market

• 24.1. USA Contraceptives Market Overview
• 24.2. USA Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contraceptives Market

• 25.1. Canada Contraceptives Market Overview
• 25.2. Canada Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contraceptives Market

• 26.1. South America Contraceptives Market Overview
• 26.2. South America Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contraceptives Market

• 27.1. Brazil Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contraceptives Market

• 28.1. Middle East Contraceptives Market Overview
• 28.2. Middle East Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contraceptives Market

• 29.1. Africa Contraceptives Market Overview
• 29.2. Africa Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contraceptives Market Competitive Landscape And Company Profiles

• 30.1. Contraceptives Market Competitive Landscape
• 30.2. Contraceptives Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Church & Dwight Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Cipla Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Reckitt Benckiser Group plc Overview, Products and Services, Strategy and Financial Analysis

31. Contraceptives Market Other Major And Innovative Companies

• 31.1. Agile Therapeutics Inc.
• 31.2. Allergan Ltd.
• 31.3. Aurobindo Pharma Limited
• 31.4. Famy Care Ltd.
• 31.5. Glenmark Pharmaceuticals Limited
• 31.6. HLL Lifecare Limited
• 31.7. Johnson & Johnson
• 31.8. Laboratoire HRA Pharma SAS
• 31.9. Lupin Limited
• 31.10. Mankind Pharma Ltd.
• 31.11. Mayer Laboratories Inc.
• 31.12. Medisafe Distribution Inc.
• 31.13. Mithra Pharmaceuticals SA
• 31.14. Mylan NV
• 31.15. Okamoto Industries Inc.

32. Global Contraceptives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contraceptives Market

34. Recent Developments In The Contraceptives Market

35. Contraceptives Market High Potential Countries, Segments and Strategies

• 35.1 Contraceptives Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Contraceptives Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Contraceptives Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer